Tuesday, September 5ISBT2006Wednesday, 6 SeptemberSATELLITE SYMPOSIUMPLENARY LECTURES44SATELLITE SYMPOSIUM13:15 – 15.15 Ballroom EastSatellite Symposium organised by ChironImpact of individual donation (ID) Nucleic Acid Testingon blood safety13.15 – 13.20 WELCOME AND OPENINGA. Heaton (Chief Medical Officer, Chiron)Introduction of Moderator: Arthur Bird MD. CEO, Western Province <strong>Blood</strong> <strong>Transfusion</strong>(WPBTS), Cape Town13.20 – 13.30 BLOOD SAFETY REASONS FOR NAT TESTINGIN A SOUTH AFRICAN ENVIRONMENTA. Heyns (South African National <strong>Blood</strong> Service, Johannesburg, South Africa)08.30 - 09.30 AuditoriumPLENARY LECTURES 4: Ethical Issues in <strong>Blood</strong> <strong>Transfusion</strong> PracticeChairs: P.F.W. Strengers, C. Bianco08.30 - 09.154PL-04-01 GROUP RIGHTS VS. THE RIGHTS OF THE INDIVIDUALS. Benatar (Groote Schuur Hospital, Dept. of Medicine, Cape Town, South Africa)09.15 - 10.004PL-04-02 ETHICS OF STEM CELL COLLECTION, STORAGE AND CLINICALAPPLICATIONA. Van Niekerk (University of Stellenbosch, South Africa)10.30 – 11.004513.30 – 13.55 AUTOMATED INDIVIDUAL DONOR NAT TESTING AND ITSIMPLICATIONS FOR POST TRANSFUSION HIV TRANSMISSION RISK INSOUTH AFRICACOFFEE BREAKR. Crookes (South African National <strong>Blood</strong> Service, Johannesburg, South Africa)13.55 – 14.20 5 YEARS OF NAT TESTING IN SINGAPORE: TRANSITIONFROM SEMI-AUTOMATED HIV/HCV (DUPLEX) TESTING TO AUTOMATEDHIV/HCV/HBV (TRIPLEX) TESTING ON PROCLEIX ® TIGRIS ® SYSTEMD. Teo (Health Sciences Authority, Singapore, Singapore)14.25 – 14.50 HBV WORLDWIDE: POLICY IMPLICATIONS OFNAT DIAGNOSIS AND EPIDEMIOLOGYB. Carman (West Scotland Specialist Virology Center, Glasgow, Scotland, United Kingdom14.50 – 15.15 DISCUSSION ON IMPLICATIONS FOR INTERMEDIATEPREVALENCE COUNTRIESModerator: Arthur Bird, Cape Town, South AfricaPanel speakers: Kap-No Lee (Korean Red Cross, Seoul, South-Korea), A. Hatzakis(National Retrovirus Reference Center, Athens, Greece)15.15 CLOSURE15.00 GENERAL EXCURSION CHAPMANS PEAK TOUR.FOR MORE INFORMATION SEE PAGE 175INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
Wednesday, 6 SeptemberISBT2006Wednesday, 6 SeptemberPARALLEL SESSIONSPARALLEL SESSIONS4610.30 - 12.00 Room: 1.41 - 1.44S16: Evidence Based <strong>Transfusion</strong> MedicineChairs: E.C. Vamvakas, W.G. van Aken10.30 - 11.004PS-16-01 NEW TRIALS TO GUIDE TRANSFUSION PRACTICE-WHAT'S NEW IN THE LAST 2 YEARSB. McClelland (Scottish National <strong>Blood</strong> <strong>Transfusion</strong> Service, Edinburgh, United Kingdom)11.00 - 11.304PS-16-02 EVIDENCE-BASED TRANSFUSION MEDICINE: TOP TENMISTAKES WHEN DOING CLINICAL RESEARCH – ARE YOU GUILTY?11.30 - 11.454PS-17-04 DOES A NEGATIVE DIRECT ANTIGLOBULIN TEST EXCLUDE WARMAUTOIMMUNE HEMOLYTIC ANEMIA? A PROSPECTIVE STUDY OF 504 CASESJ.H. Sachs, S. Santoso, G. Bein (Justus Liebig University Giessen, Giessen, Germany)11.45 - 12.004PS-17-05 EFFECT OF A SINGLE GIFT OF ANTENATAL ANTI-D-PROPHYLAXISWITH 1000 IU IN WEEK 30 ON THE INCIDENCE OF RHESUS-D-IMMUNIZATIONIN THE FIRST TRIMESTER OF NEXT PREGNANCYJ.M. Koelewijn, M. de Haas, T.G.M. Vrijkotte, G.J. Bonsel, C.E. van der Schoot(Sanquin Research and Landsteiner Lab, Amsterdam, Netherlands)47N. Heddle (McMaster University, Hamilton, Canada)11.30 - 12.004PS-16-03 QUALITATIVE RESEARCH IN TRANSFUSION MEDICINE:CLOSING THE GAP10.30 - 12.00 Room: 1.61 - 1.64S18: IPFA Symposium: Quality and safety of plasma andplasma productsS. Whittaker (McMaster University, Hamilton, Canada)Chairs : T. Burnouf, A. Padilla10.30 - 12.00 Ballroom WestS17: The Immune Haemolytic AnaemiasChairs : W. Mayr, M. Contreras10.30 - 10.504PS-17-01 PATHOGENESIS OF AUTOIMMUNE HAEMOLYTIC ANAEMIAS(AIHA)10.30 - 10.504PS-18-01 PLASMA FRACTIONATION: PROGRESS AND CURRENT ISSUEST. Burnouf (Human Plasma Product Services, Lille, France)10.50 - 11.104PS-18-02 THE IMPACT OF THE PLASMA MASTER FILE ON BLOODAND PLASMA COLLECTION ORGANIZATIONSR. Buchel (PPTA Source / EPCC, Brussels, Belgium)J. Semple (St Michael's Hospital, Toronto, Canada)10.50 - 11.104PS-17-02 TREATMENT OF AIHA11.10 - 11.304PS-18-03 WHO RECOMMENDATIONS ON THE PRODUCTION,CONTROL AND REGULATION OF PLASMA FOR FRACTIONATIONP. Ness (John Hopkins Medical Institution, Baltimore, United States of America)A. Padilla (World Health Organization, Geneve, Switzerland)11.10 - 11.304PS-17-03 LABORATORY APPROACH TO DIAGNOSIS ANDTRANSFUSION POLICY IN AIHA11.30 - 11.504PS-18-04 CLINICAL OUTCOMES FROM THE EVOLUTION IN QUALITYOF PLASMA-DERIVED PRODUCTSM. de Haas (Sanquin, Diagnostics Services, Amsterdam, Netherlands)C. Dash (Sanquin, Amsterdam, Netherlands)11.50 - 12.00DISCUSSION TIMEINTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT
- Page 24 and 25: XXIX th International Congressof th
- Page 26 and 27: ISBT2006WORDS OF WELCOME5It is with
- Page 28 and 29: ISBT20068ORGANISATION - COMMITTEESO
- Page 30 and 31: Programme per DayISBT2006Programme
- Page 32 and 33: ISBT2006Programme per DayTHURSDAY,
- Page 34 and 35: Sunday, 3 SeptemberISBT2006Sunday,
- Page 36 and 37: Sunday, 3 SeptemberISBT2006Monday,
- Page 38 and 39: Monday, 4 SeptemberISBT2006Monday,
- Page 40 and 41: Monday, 4 SeptemberISBT2006Monday,
- Page 42 and 43: Monday, 4 SeptemberISBT2006Monday,
- Page 44 and 45: Monday, 4 SeptemberISBT2006Tuesday,
- Page 48 and 49: Wednesday, 6 SeptemberISBT2006Wedne
- Page 50 and 51: Wednesday, 6 SeptemberISBT2006Wedne
- Page 52 and 53: Wednesday, 6 SeptemberISBT2006Wedne
- Page 54 and 55: Wednesday, 6 SeptemberISBT2006Thurs
- Page 56 and 57: Thursday, 7 SeptemberISBT2006Thursd
- Page 58 and 59: PostersISBT2006PostersTOPIC 01.1The
- Page 60 and 61: PostersISBT2006PostersTOPIC 01.2TOP
- Page 62 and 63: PostersISBT2006PostersTOPIC 01.2TOP
- Page 64 and 65: PostersISBT2006PostersTOPIC 01.5The
- Page 66 and 67: PostersISBT2006PostersTOPIC 01.6TOP
- Page 68 and 69: PostersISBT2006PostersTOPIC 01.8The
- Page 70 and 71: PostersISBT2006PostersTOPIC 02.1TOP
- Page 72 and 73: PostersISBT2006PostersTOPIC 02.1TOP
- Page 74 and 75: PostersISBT2006PostersTOPIC 02.1TOP
- Page 76 and 77: PostersISBT2006PostersTOPIC 02.2TOP
- Page 78 and 79: PostersISBT2006PostersTOPIC 02.4TOP
- Page 80 and 81: PostersISBT2006PostersTOPIC 03.2The
- Page 82 and 83: PostersISBT2006PostersTOPIC 04.3The
- Page 84 and 85: PostersISBT2006PostersTOPIC 05.2The
- Page 86 and 87: PostersISBT2006PostersTOPIC 05.2TOP
- Page 88 and 89: PostersISBT2006PostersTOPIC 07.2The
- Page 90 and 91: PostersISBT2006PostersTOPIC 08.1-3T
- Page 92 and 93: PostersISBT2006PostersTOPIC 09.2TOP
- Page 94 and 95: PostersISBT2006PostersTOPIC 10.1TOP
- Page 96 and 97:
PostersISBT2006PostersTOPIC 11.1The
- Page 98 and 99:
PostersISBT2006PostersTOPIC 11.4The
- Page 100 and 101:
PostersISBT2006PostersTOPIC 13.0TOP
- Page 102 and 103:
PostersISBT2006PostersTOPIC 15.0TOP
- Page 104 and 105:
ISBT Business MeetingsISBT2006Key I
- Page 106 and 107:
Key InformationISBT2006Key Informat
- Page 108 and 109:
Scientific InformationISBT2006Scien
- Page 110 and 111:
Registration InformationISBT2006Soc
- Page 112 and 113:
ISBT2006FLOORPLANGROUND FLOORFLOORP
- Page 114 and 115:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 116 and 117:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 118 and 119:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 120 and 121:
ISBT2006LIST OF EXHIBITORSin terms
- Page 122 and 123:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 124 and 125:
ISBT2006LIST OF EXHIBITORSLIST OF E
- Page 126 and 127:
ISBT2006LIST OF EXHIBITORS59 Cape C
- Page 128 and 129:
ISBT2006MAP OF CAPE TOWNSPEAKERS IN
- Page 130 and 131:
International Society ofBlood Trans
- Page 132:
ISBT2006NOTES216INTERNATIONAL SOCIE